Effects of 17β-estradiol on peripheral and coronary vasomotor function in postmenopausal women

被引：0
|
作者：
Macquin-Mavier, I [1 ]
Partovian, C [1 ]
机构：
[1] Hop Henri Mondor, Serv Pharmacol Clin, F-94010 Creteil, France
来源：
THERAPIE | 1999年 / 54卷 / 03期
关键词：
17; beta-estradiol; menopause; circulation; endothelium;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Women appear to be protected, until the menopause, from the development of coronary artery syndromes. This protective effect seems to be due to the beneficial effect of ovarian hormones, in particular oestrogens. A number of potential mechanisms for the protective effect of oestrogens have been proposed. An important postulated mechanism could be by improving the function of vascular endothelium. In this review, we present the currently published studies that have evaluated the effects of 17 beta-estradiol, the only oestrogen used in France for hormone replacement therapy, on peripheral and coronary vasomotor function in postmenopausal women.
引用
收藏
页码：353 / 355
页数：3
相关论文
共 50 条
  • [21] Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women
    Hedrick, Richard E.
    Ackerman, Ronald T.
    Koltun, William D.
    Halvorsen, Mark B.
    Lambrecht, Lawrence J.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2009, 16 (01): : 132 - 140
  • [22] Endogenous estradiol and coronary calcifications in postmenopausal women
    Lobo, Roger
    CLIMACTERIC, 2010, 13 (05) : 502 - 503
  • [23] Vasomotor Effects of Bazedoxifene in Nonflushing Postmenopausal Women
    Bachmann, Gloria
    Crosby, Uel
    Feldman, Robert A.
    Ronkin, Sheila
    Constantine, Ginger
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (06): : 1212 - 1212
  • [24] NEUROENDOCRINE AND CLINICAL EFFECTS OF TRANSDERMAL 17-BETA-ESTRADIOL IN POSTMENOPAUSAL WOMEN
    CAGNACCI, A
    MELIS, GB
    SOLDANI, R
    PAOLETTI, AM
    GAMBACCIANI, M
    SPINETTI, A
    FIROETTI, P
    MATURITAS, 1991, 13 (04) : 283 - 296
  • [25] The effect of transdermal 17β-estradiol or oral statin therapy on endothelial function in postmenopausal women
    Guevara, I
    Zdzienicka, A
    Bartuoe, S
    Krzysiek, J
    Milewicz, T
    Legutko, J
    Dubiel, J
    Malczewska, M
    Dembinska-Kieæ, A
    XXI CONGRESS OF THE EUROPEAN SOCIETY OF CARDIOLOGY, 1999, : 157 - 164
  • [26] 17β-estradiol decreases endothelin-l levels in the coronary circulation of postmenopausal women with coronary artery disease
    Webb, CM
    Ghatei, MA
    McNeill, JG
    Collins, P
    CIRCULATION, 2000, 102 (14) : 1617 - 1622
  • [27] The effects of micronutrient supplementation on vasomotor symptoms in postmenopausal women
    Andrikoula, M.
    Baker, D.
    Nesic, J.
    Liao, L. M.
    Duka, T.
    Prelevic, G. M.
    CLIMACTERIC, 2011, 14 (05) : 544 - 550
  • [28] EFFECTS OF A 17-BETA ESTRADIOL TRANSDERMAL GEL ON HORMONE LEVELS IN POSTMENOPAUSAL WOMEN
    ARAYA, V
    CONTRERAS, P
    AGUIRRE, C
    FORADORI, A
    REVISTA MEDICA DE CHILE, 1995, 123 (09) : 1116 - 1121
  • [29] Effects of a new hormone therapy, drospirenone and 17-β-estradiol, in postmenopausal women with hypertension
    White, William B.
    Hanes, Vladimir
    Chauhan, Vijay
    Pitt, Bertram
    HYPERTENSION, 2006, 48 (02) : 246 - 253
  • [30] Population pharmacokinetic/pharmacodynamic evaluation of low-dose drospirenone with 17β-estradiol in postmenopausal women with moderate to severe vasomotor symptoms
    Sutter, Gabriele
    Schmelter, Thomas
    Gude, Kerstin
    Schaefers, Matthias
    Gerlinger, Christoph
    Archer, David F.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2014, 21 (03): : 236 - 242
12345